Cardinal Health Q2 EPS Climbs 10% to $2.63, Revenue Tops $65.6 Billion
Cardinal Health posted Q2 fiscal 2026 adjusted EPS of $2.63, beating estimates by 10%, and reported revenues of $65.6 billion, topping forecasts by 0.9%. The company’s 15% long-term earnings growth rate outpaced the 9.6% industry average, with earnings surpassing estimates in each of the past four quarters (9.3% average surprise).
1. Strong Q2 Fiscal 2026 Results
Cardinal Health reported adjusted EPS of $2.63 for Q2 fiscal 2026, representing a 10% upside versus consensus. Revenue reached $65.6 billion, exceeding forecasts by 0.9%, driven by resilient pharmaceutical distribution and operational efficiencies.
2. Growth Outlook and Industry Comparison
The company’s expected long-term earnings growth rate stands at 15%, well above the industry’s 9.6% average. CAH has surpassed earnings estimates in each of the last four quarters, delivering an average surprise of 9.3%, underlining consistent execution and strong market positioning.